28 Jan 2015
The FDA recently approved a parathyroid hormone product, Natpara (NPS Pharmaceuticals), to control hypocalcaemia in patients with hypoparathyroidism.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024